{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:10:58Z","timestamp":1771827058269,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This article presents the current structure, data collection methods, coverage, and limitations of the Lithuanian Multiple Sclerosis (MS) Registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The Lithuanian MS Registry, established by the Lithuanian Neurologists' Association, began its activities in 2013. All three national centers providing MS treatment in Lithuania have secure access to their respective patient data and can enter new clinical information into the registry. Adult individuals with a suspected or confirmed diagnosis of MS who receive care in Lithuania and provide written informed consent are eligible for inclusion in the Multiple Sclerosis Patient Surveillance System registry. For the present analysis, a dataset comprising all records from February 1, 2013, to January 1, 2024, was extracted on June 17, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The registry collects individual data on demographics, results from specific diagnostic procedures (such as cerebrospinal fluid analysis, evoked potentials), clinical evaluations conducted at every visit (based on the Expanded Disability Status Scale), treatment, and relapses (including their dates and whether corticosteroid treatment was administered). Currently, the registry includes 2,923 patients. Of these, 1,651 patients are classified as in active follow-up (those with at least one recorded visit since January 1, 2021) and represent less than half of the total MS population in Lithuania (47.3%). The registry covers approximately 69.5%\u221274.6% of all patients receiving disease-modifying therapy in the country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the registry has been operating for more than a decade, challenges remain in patient enrollment and ensuring high-quality data collection. Strengthening validation processes is essential to ensure the registry's reliability and utility in both clinical practice and research settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1728596","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:28:05Z","timestamp":1771824485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The Lithuanian multiple sclerosis registry: current framework and quality challenges"],"prefix":"10.3389","volume":"17","author":[{"given":"Julija","family":"Isa\u010denko","sequence":"first","affiliation":[{"name":"Department of Neurology, Lithuanian University of Health Sciences Kaunas Clinics","place":["Kaunas, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Musneckien\u0117","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical Academy, Lithuanian University of Health Sciences","place":["Kaunas, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Kizlaitien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Giedraitien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romualdas","family":"Kizlaitis","sequence":"additional","affiliation":[{"name":"Independent Researcher","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Malcien\u0117","sequence":"additional","affiliation":[{"name":"Department of Neural Diseases and Rehabilitation, Klaipeda University Hospital","place":["Klaipeda, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalius","family":"Jatu\u017eis","sequence":"additional","affiliation":[{"name":"Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gintaras","family":"Kaubrys","sequence":"additional","affiliation":[{"name":"Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiva","family":"Rastenyt\u0117","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical Academy, Lithuanian University of Health Sciences","place":["Kaunas, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jval.2016.02.007","article-title":"Balancing the optimal and the feasible: a practical guide for setting up patient registries for the collection of real-world data for health care decision making based on Dutch experiences","volume":"20","author":"de Groot","year":"2017","journal-title":"Value Heal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0250820","DOI":"10.1371\/journal.pone.0250820","article-title":"Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry","volume":"16","author":"Id","year":"2021","journal-title":"PloS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e200425","DOI":"10.1212\/CPJ.0000000000200425","article-title":"A real-world prospective multiple sclerosis pregnancy registry in the United States: PREG-MS","volume":"15","author":"Houtchens","year":"2025","journal-title":"Neurol Clin Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11795735241262743","DOI":"10.1177\/11795735241262743","article-title":"Real-world effectiveness of cladribine as an escalation strategy for MS : insights from the Czech nationwide ReMuS registry","volume":"16","author":"Potuznik","year":"2024","journal-title":"J Cent Nerv Syst Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ncl.2023.06.003","article-title":"Leveraging real-world evidence and observational studies in treating multiple sclerosis","volume":"42","author":"Aboseif","year":"2024","journal-title":"Neurol Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1007\/s00415-024-12303-6","article-title":"Big Multiple Sclerosis Data network: an international registry research network","volume":"271","author":"Glaser","year":"2024","journal-title":"J Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"20552173231153557","DOI":"10.1177\/20552173231153557","article-title":"Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers","volume":"9","author":"Forsberg","year":"2023","journal-title":"Mult Scler J \u2013 Exp Transl Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562864231198963","article-title":"The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe","volume":"16","author":"Nicholas","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e01921","DOI":"10.1002\/brb3.1921","article-title":"The Danish Multiple Sclerosis Registry","volume":"11","author":"Magyari","year":"2021","journal-title":"Brain Behav"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103928","article-title":"Global assessment of characteristics of multiple sclerosis registries; a systematic review","author":"Ezabadi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"103344","DOI":"10.1016\/j.msard.2021.103344","article-title":"Pediatric-onset multiple sclerosis in Poland: a registry-based retrospective cohort study","volume":"57","author":"Brola","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-018-1118-0","article-title":"The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research","volume":"18","author":"Steinemann","year":"2018","journal-title":"BMC Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.msard.2018.09.032","article-title":"Multiple sclerosis registries in Europe \u2013 An updated mapping survey","volume":"27","author":"Glaser","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10072-018-3610-0","article-title":"The Italian multiple sclerosis register","volume":"40","author":"Trojano","year":"2019","journal-title":"Neurol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5507\/bp.2023.015","article-title":"The Czech National MS Registry (ReMuS): data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021","volume":"168","author":"Stastna","year":"2023","journal-title":"Biomed Pap."},{"key":"B16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/EDE.0000000000000948","article-title":"Validation of the Swedish multiple sclerosis register: further improving a resource for pharmacoepidemiologic evaluations","volume":"30","author":"Alping","year":"2019","journal-title":"Epidemiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ane.12425","article-title":"The Swedish MS registry \u2013 clinical support tool and scientific resource","volume":"132","author":"Hillert","year":"2015","journal-title":"Acta Neurol Scand."},{"key":"B18","doi-asserted-by":"publisher","first-page":"103954","DOI":"10.1016\/j.msard.2022.103954","article-title":"Fatigue in multiple sclerosis: a UK MS-register based study","volume":"64","author":"Moore","year":"2022","journal-title":"Mult Scler Relat Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e104604","DOI":"10.1371\/journal.pone.0104604","article-title":"Physical disability, anxiety and depression in people with MS: an internet-based survey via the UK MS Register","volume":"9","author":"Jones","year":"2014","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7224\/1537-2073.2023-082","article-title":"MyMS: an interface for patient-reported outcomes for Finnish individuals with multiple sclerosis","volume":"26","author":"Viitala","year":"2024","journal-title":"Int J MS Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ane.12030","article-title":"The Norwegian multiple sclerosis registry and biobank","volume":"126","author":"Myhr","year":"2012","journal-title":"Acta Neurol Scand."},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ane.12427","article-title":"The Norwegian Multiple Sclerosis Registry and Biobank","volume":"132","author":"Myhr","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"B23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/1352458517698250","article-title":"Landscape of MS patient cohorts and registries: recommendations for maximizing impact","volume":"24","author":"Bebo","year":"2018","journal-title":"Mult Scler J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/13524585231216004","article-title":"Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: recommendations from a global task force","volume":"30","author":"Parciak","year":"2024","journal-title":"Mult Scler."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1728596\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:28:05Z","timestamp":1771824485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1728596\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":24,"alternative-id":["10.3389\/fneur.2026.1728596"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1728596","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1728596"}}